Home › Malattie cardiovascolari › Florida › Orlando
Studi clinici su Malattie cardiovascolari a Orlando, FL
14 studi su Malattie cardiovascolari cercano partecipanti presso sedi a Orlando e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
In reclutamentoFase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · a 6 mi di distanza
- Omega Research Orlando, Altamonte Springs · a 9 mi di distanza
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
In reclutamentoFase 3
- Florida Institute for Clinical Research, Orlando
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
In reclutamentoFase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · a 5 mi di distanza
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
In reclutamentoFase 3
- Clinical Trial Site, Orlando
- Clinical Trial Site, Winter Park · a 5 mi di distanza
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
In reclutamentoFase 3
- Clinical Research Site, Kissimmee · a 16 mi di distanza
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
In reclutamento
- Advent Health, Orlando
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
In reclutamentoFase 2
- Clinical Research Site, Kissimmee · a 16 mi di distanza
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
In reclutamentoStudio osservazionale
- Arnold Palmer Hospital for Children, Orlando
- Nemours Children's Hospital, Orlando
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
In reclutamentoFase 3
- Research Site, Orlando
- Research Site, Orlando
- Research Site, Orlando
- e altri 2
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
In reclutamentoFase 3
- Clinical Site Partners Orlando dba Flourish Research, Winter Park · a 5 mi di distanza
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
In reclutamentoFase 3
- FC Site Partners Miami, Winter Park · a 5 mi di distanza
SPYRAL GEMINI Pilot Study
In reclutamento
- Orlando Health Heart & Vascular Institute, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
In reclutamento
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
In reclutamentoFase 3
- AdventHealth, Orlando
Studi su Malattie cardiovascolari in altre città
- Boston, MA37 studi
- New York City, NY33 studi
- Washington, DC29 studi
- Houston, TX24 studi
- Dallas, TX23 studi
- Atlanta, GA22 studi
- Cleveland, OH22 studi
- Chicago, IL21 studi
- Philadelphia, PA21 studi
- Pittsburgh, PA20 studi
- St. Louis, MO20 studi
- San Francisco, CA18 studi
Altri studi a Orlando
- Cancro del polmone non a piccole cellule44 studi
- Obesità31 studi
- Cancro metastatico29 studi
- Sovrappeso27 studi
- Morbo di Alzheimer25 studi
- Diabete di tipo 224 studi
- Cancro (tutti i tipi)24 studi
- Cancro al seno23 studi
- Cancro ovarico22 studi
- Colite ulcerosa22 studi
- Cancro ai polmoni21 studi
- Cancro colorettale19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.